Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT00043563
This study will compare the effectiveness of cognitive-behavior therapy (CBT) to a minimal attention control (AC) condition for treatment of pediatric trichotillomania (TTM).
Looking for future studies?
Notify Me8 year–17 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.
Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
Semi-structured interview about hair-pulling and related symptoms
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05003401
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT04241120
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT01875445
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00775229
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial Details